Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 22, 2016
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 07, 2015
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 19, 2014
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 10, 2014
Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.
Journal: Blood
Published: December 06, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026